12.01.2017 • Topics

Johnson Matthey Launches New Online Catalyst Store

Johnson Matthey announced the launch of its new online catalyst store which, according to the company, provides customers with easy access to research quantities of commercial grade ligands and catalysts, to accelerate development of efficient and economic processes to pharmaceuticals, agrochemicals, and other applications.

Customers can now easily search for and directly buy a range of homogeneous catalysts for cross-coupling and asymmetric transformations. A wider variety of Johnson Matthey Fine Chemicals products, including heterogeneous catalysts and proprietary enzymes for biocatalysis, will become available online later this year.

The store integrates with the Johnson Matthey Catalyst Reaction Guide (CRG) app, and together these allow customers to search for an efficient catalyst for a wide range of reactions and then directly purchase their optimal catalyst in just a few moments.

“The new Johnson Matthey Catalyst Store provides our customers with direct access to our world-leading catalysts,” commented Gerard Compagnoni, general manager Johnson Matthey Catalysts & Chiral Technologies. “Not only will this make catalyst sourcing simpler, but customers can be assured that the products they use for development will meet the same quality and performance as they scale up for commercial production.”

Interview

Driving Sustainability Through Collaboration
Building Green Practices Across the Chemical Supply Chain

Driving Sustainability Through Collaboration

Together for Sustainability (TfS) is a pioneering, member-led initiative working to accelerate sustainable and resilient chemical supply chains. TfS President Jennifer Jewson discusses the origins of TfS, its evolving goals, its present-day challenges, and the initiative’s enduring impact and outlook for the future.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read